The treatment with IGS-2.7 rescued the loss of both Nissl and ChAT-positive cells in TDP-43 (A315T) transgenic mice (Fig. 2), stressing an important neuroprotective effect in this experimental model of ALS. Here, CHAT is linked to amyotrophic lateral sclerosis.